These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4819974)

  • 1. Tolerance to delta9-THC in adult rats with differential delta9-THC exposure when immature or during early adulthood.
    Barnes C; Fried PA
    Psychopharmacologia; 1974 Jan; 34(3):181-90. PubMed ID: 4819974
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of two tetrahydrocannabinols (delta9-THC and delta8-THC) on water intake in water deprived rats: implications for behavioral studies on marijuana compounds.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1973 Jun; 30(4):315-22. PubMed ID: 4722202
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of tetrahydrocannabinols (delta8-THC and delta9-THC) on body weight, food, and water intake in rats.
    Sjödén PO; Järbe TU; Henriksson BG
    Pharmacol Biochem Behav; 1973; 1(4):395-9. PubMed ID: 4777577
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
    Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters influencing the effect of delta9-THC on activity wheel behavior.
    Fried PA
    Pharmacol Biochem Behav; 1974 May; 2(3):435-8. PubMed ID: 4837913
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine effects of chronic intraventricular administration of delta9-tetrahydrocannabinol to prepuberal and adult male rats.
    Collu R
    Life Sci; 1976 Jan; 18(2):223-30. PubMed ID: 1256238
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term administration and withdrawal of tetrahydrocannabinols (delta 8-THC and delta 9-THC) on open-field behavior in rats.
    Sjödén PO; Järbe TU; Henriksson BG
    Pharmacol Biochem Behav; 1973; 1(3):243-9. PubMed ID: 4798094
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.
    Greenberg I; Kuhn D; Appel JB
    Pharmacol Biochem Behav; 1975; 3(5):931-4. PubMed ID: 1208637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-field behavior and acquisition of discriminative response control in delta 9-THC.
    Järbe TU; Henriksson BG
    Experientia; 1973 Oct; 29(10):1251-3. PubMed ID: 4758932
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees.
    Ferraro DP; Grilly DM
    Psychopharmacologia; 1974 Jun; 37(4):127-38. PubMed ID: 4844118
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: the role of drug disposition.
    Siemens AJ; Doyle OL
    Pharmacol Biochem Behav; 1979 Jan; 10(1):49-55. PubMed ID: 441094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition and extinction of variable interval schedule behavior by rats under delta9-tetrahydrocannabinol.
    Ferraro DP; Gluck JP; Herndon GB
    Pharmacol Biochem Behav; 1974; 2(4):487-91. PubMed ID: 4421520
    [No Abstract]   [Full Text] [Related]  

  • 20. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.